Prockop, S., Mahadeo, K. M., Beitinjaneh, A., Choquet, S., Stiff, P., Reshef, R., Satyanarayana, G., Dahiya, S., Parmar, H., Ye, W., Gamelin, L., & Dinavahi, R. (2021). Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE). Blood, 138(Supplement 1), 301–301. https://doi.org/10.1182/blood-2021-147274

Ricker, E. C., Ryu, Y. K., & Amengual, J. E. (2021). Daratumumab Plus Chemotherapy Induces Complete Responses in a Consecutive Series of Four Patients with Plasmablastic Lymphoma. Blood, 138(Supplement 1), 4573–4573. https://doi.org/10.1182/blood-2021-150800

Afify, Z., Orjuela, M., Smith, C. M., Dalal, M., Ford, J. B., Pillai, P., Robles, J., Reddy, S., McCormack, S., Ehrhardt, M. J., Ureda, T., Edington, H., Miller, T. P., Rubinstein, J., Marks, L., & Mason, C. C. (2021). Outcome of Post Solid Organ Transplant Burkitt Lymphoma (PSOT-BL): A Report from the Pediatric PTLD Collaborative (PPC). Blood, 138(Supplement 1), 2498–2498. https://doi.org/10.1182/blood-2021-149033

Lue, J. K., Ma, H., Marchi, E., Spivack, J. H., & O’Connor, O. A. (2021). Peripheral T-Cell Lymphoma Involvement of the Central Nervous System: Impact of Novel Therapeutics on Clinical Outcomes. Blood, 138(Supplement 1), 2469–2469. https://doi.org/10.1182/blood-2021-144933

Wang, M., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Jurczak, W., Tan, X. N., Lewis, K., Fenske, T. S., Coombs, C. C., Flinn, I. W., Lewis, D. J., Le Gouill, S., Palomba, M. L., Woyach, J. A., Pagel, J. M., Lamanna, N., Cohen, J. B., … Cheah, C. Y. (2021). Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study. Blood, 138(Supplement 1), 381–381. https://doi.org/10.1182/blood-2021-149138

Leeman-Neill, R. J., Thakkar, D., Ondrejka, S. L., Hsi, E. D., Chadburn, A., Mejia Saldarriaga, M., Rutherford, S. C., McCall, C. M., Aljurf, T., McKinney, M., Koff, J. L., Jaye, D. L., Cohen, J. B., Soliman, D. S., Louissaint, A., Ong, C. K., Cheng, C. L., Lee, L., Behdad, A., … Bhagat, G. (2021). Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma. Blood, 138(Supplement 1), 2398–2398. https://doi.org/10.1182/blood-2021-149745

Rivas, M. A., Durmaz, C., Kloetgen, A., Chin, C. R., Chen, Z., Bhinder, B., Koren, A., Viny, A. D., Scharer, C. D., Boss, J. M., Elemento, O., Mason, C. E., & Melnick, A. M. (2021). Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.688493

Geskin, L. J., Garcia-Saleem, T., Akilov, O. E., Enz, P., Guenova, E., Ortiz-Romero, P. L., Papadavid, E., Quaglino, P., Rozati, S., Stonesifer, C., Burns, A., Khaleel, A., & Scarisbrick, J. J. (2021). International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19. European Journal of Cancer, 156, S32–S33. https://doi.org/10.1016/s0959-8049(21)00685-7

Han, J., Zhu, Z., Zhang, C., & Xie, H. (2021). Successful Endoscopic Resection of Primary Rectal Mucosa-Associated Lymphoid Tissue Lymphoma by Endoscopic Submucosal Dissection: A Case Report. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.715256

Herrera, A. F., Ahn, K. W., Litovich, C., Chen, Y., Assal, A., Bashir, Q., Bayer, R.-L., Coleman, M., DeFilipp, Z., Farhadfar, N., Greenwood, M., Hahn, T., Horwitz, M., Jacobson, C., Jaglowski, S., Lachance, S., Langston, A., Mattar, B., Maziarz, R. T., … Hamadani, M. (2021). Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome. Blood Advances, 5(18), 3528–3539. https://doi.org/10.1182/bloodadvances.2021004865

Catenacci, D. V., Liao, C.-Y., Maron, S., Solomon, B. J., Mahipal, A., Johnson, M. L., Carbone, D., Henick, B. S., Johnson, B., Roychowdhury, S., Mody, K., Ahn, D. H., Bournazou, E., Schenk, D., Kounlavouth, S., Kraemer, L., Talbot, G., Rousseau, R., Ferguson, A. R., & Spira, A. (2021). 960MO Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC. Annals of Oncology, 32, S830–S831. https://doi.org/10.1016/j.annonc.2021.08.1345